A challenge that has vexed health systems and payers for decades is the inability to fully quantify the long-term impacts of steroid-toxicity. Set to change that paradigm is the GTI-MD, an ...
“Every milligram that helps control the disease is a good milligram, but every milligram we can spare is an even better one.” Frank Buttgereit, MD is a Professor of Rheumatology and Deputy Head of ...
When the stakes involve patient outcomes and the credibility of clinical trials in the medical, health and pharmaceutical sectors, maintaining data accuracy, integrity and privacy is essential. In ...
Early results from a pilot study into the impact of steroid-toxicity on pediatric lupus nephritis patients suggest that children experience a high burden of steroid-toxicity and that variation in ...
“Infection is probably the biggest morbidity and mortality risk early on, and steroids dramatically increase the risk of infection." Joyce Chang, MD MSCE is a pediatric rheumatologist at Boston ...